ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989

University of Oklahoma Wins Planning Grant; Three Mile Island Follow-Up Finds No Significant Increase In Cancer Deaths

November 2, 2002

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

Ford Named Acting CORB Chief; Hunter CCOP Coordinator

July 10, 1987

Cancer Act 25th Year: cancer Mortality Rate Began decline In 1990s, NCI, ACS Studies Find

November 22, 1996